E
Founded 2010. Transatlantic VC (Edinburgh/Bethesda). Fund IV closing $145m+ (Jan 2026). Invests £0.5-5m early-stage. Portfolio: Apellis (FDA/EMA approved), Curve Therapeutics (£40.5m Series A), Enterprise Therapeutics, Kynos, NodThera, Harpoon Medical. 10-person team. Active value-add: team building, regulatory strategy, IP development.
Check Size
£500K - £5M
Investment Focus
GeographyScotland
OtherUniversity Spinouts
Investment Thesis
Seed-Series A therapeutics, diagnostics, medtech. Targets oncology, cardiometabolic, autoimmunity, neurology. Strong IP & clear regulatory paths critical. Builds from academic research. Avoids: late-stage; limited clinical evidence. UK/US focused. Values: university spinouts, unmet medical needs, founder-scientist partnerships.
Interested in connecting?
Visit their website or reach out directly.